Suppr超能文献

蛋白激酶C对P1075(一种K(ATP)通道开放剂)诱导的大鼠离体主动脉86Rb+外流和血管舒张的抑制作用。

Inhibition by protein kinase C of the 86Rb+ efflux and vasorelaxation induced by P1075, a K(ATP) channel opener, in rat isolated aorta.

作者信息

Linde C, Löffler C, Quast U

机构信息

Department of Pharmacology, Medical Faculty, University of Tübingen, Germany.

出版信息

Naunyn Schmiedebergs Arch Pharmacol. 1997 Sep;356(3):425-32. doi: 10.1007/pl00005072.

Abstract

In rat aortic rings, P1075, an opener of ATP-dependent potassium channels (K(ATP) channels), produces relaxation and 86Rb+ efflux from preloaded tissues; the increase in 86Rb+ efflux qualitatively reflects K(ATP) channel opening. In this study we have investigated the effects of protein kinase C modulation on the 86Rb+ efflux stimulating, the vasorelaxant and the binding properties of P1075. Phorbol 12,13-dibutyrate (PDBu), a direct activator of protein kinase C, inhibited the 86Rb+ efflux produced by P1075 with an IC50 value of 20+/-2 nM. Phorbol 12-myristate 13-acetate (PMA), another stimulator of protein kinase C, was 150 times weaker in this respect whereas 4alpha-PDBu, the inactive stereoisomer of PDBu, was ineffective. Staurosporine (300 nM), an inhibitor of protein kinase C, induced a small but significant increase of P1075-induced tracer efflux and partially reversed the inhibitory effect of PDBu on P1075-stimulated tracer efflux. The vasorelaxant effect of P1075 was inhibited only to a moderate degree by PDBu at concentrations which inhibited P1075-induced 86Rb+ efflux to >90%; however, in the presence of PDBu, the relaxation kinetics of P1075 were increasingly slowed. The vasorelaxant effect of P1075 in the presence of PDBu was still sensitive to inhibition by glibenclamide (100 nM), the standard inhibitor of the K(ATP) channel openers. Specific binding of [3H]-P1075 to rat aortic rings was unaffected by PDBu and PMA even in the micromolar concentration range. The data show that stimulation of protein kinase C inhibits the K+ channel opening effect of P1075 in rat aorta and suggest that protein kinase C may exert a weak tonic inhibition on the K(ATP) channels in this vessel under quasiphysiological conditions. At concentrations of PDBu which essentially abolished P1075-induced tracer efflux, the glibenclamide-sensitive vasorelaxant effect of P1075 was slowed down but not prevented; this supports earlier suggestions that K+ channel openers are also able to relax smooth muscle cells by a mechanism independent of K(ATP) channel opening.

摘要

在大鼠主动脉环中,P1075是一种ATP依赖性钾通道(K(ATP)通道)开放剂,可使预加载组织产生舒张并使86Rb+外流;86Rb+外流的增加定性地反映了K(ATP)通道的开放。在本研究中,我们研究了蛋白激酶C调节对P1075刺激的86Rb+外流、血管舒张作用及结合特性的影响。佛波醇12,13 - 二丁酸酯(PDBu)是蛋白激酶C的直接激活剂,可抑制P1075产生的86Rb+外流,IC50值为20±2 nM。另一种蛋白激酶C刺激剂佛波醇12 - 肉豆蔻酸酯13 - 乙酸酯(PMA)在这方面的作用弱150倍,而PDBu的无活性立体异构体4α - PDBu则无作用。蛋白激酶C抑制剂星形孢菌素(300 nM)可使P1075诱导的示踪剂外流有小幅但显著的增加,并部分逆转PDBu对P1075刺激的示踪剂外流的抑制作用。PDBu在抑制P1075诱导的86Rb+外流至>90%的浓度下,仅对P1075的血管舒张作用有中度抑制;然而,在PDBu存在的情况下,P1075的舒张动力学逐渐减慢。在PDBu存在的情况下,P1075的血管舒张作用仍对K(ATP)通道开放剂的标准抑制剂格列本脲(100 nM)敏感。即使在微摩尔浓度范围内,[3H] - P1075与大鼠主动脉环的特异性结合也不受PDBu和PMA的影响。数据表明,蛋白激酶C的激活抑制了P1075在大鼠主动脉中对K+通道的开放作用,并提示在准生理条件下,蛋白激酶C可能对该血管中的K(ATP)通道发挥微弱的强直抑制作用。在PDBu浓度基本消除P1075诱导的示踪剂外流时,P1075对格列本脲敏感的血管舒张作用虽减慢但未被阻止;这支持了早期的观点,即K+通道开放剂也能够通过一种独立于K(ATP)通道开放的机制使平滑肌细胞舒张。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验